LncRNA MBLN1-AS1 inhibits the progression of retinoblastoma through targeting miR-338-5p-Wnt/β-catenin signaling pathway
Crossref DOI link: https://doi.org/10.1007/s00011-020-01432-z
Published Online: 2021-01-16
Published Print: 2021-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Xu, Lei
Zhu, Shenyu
Tang, Aidong
Liu, Wanrong http://orcid.org/0000-0003-4377-2441
Text and Data Mining valid from 2021-01-16
Version of Record valid from 2021-01-16
Article History
Received: 19 November 2020
Revised: 7 December 2020
Accepted: 13 December 2020
First Online: 16 January 2021
Compliance with ethical standards
:
: There are no conflict of interest in this investigation.